Department of Neurology
Leading the Field for Over 100 Years
As one of the first neurology departments in the country, we have provided generations of physicians and scientists with the knowledge, skills and compassion necessary to provide high-quality patient care.
Outstanding Care for an Outstanding Community
Our goal is to provide outstanding care for patients with disease affecting the nervous system, while also advancing our understanding and treatment of these conditions through research and other scholarly work. We believe we can better achieve this goal by fostering an environment that promotes health and wellness not only within the department but also across all segments of our community.
Are you a patient or caregiver?
YOU CAN HELP TRANSFORM CARE
By supporting one of the nation’s leading neurology departments, your gift directly impacts patients and families facing debilitating diseases, such as Alzheimer’s, Parkinson’s and epilepsy.
ONE OF THE FIRST, ONE OF THE BEST
80
Full-time Faculty
200+
Annual Articles in Peer-Reviewed Journals
9th
Nationally in Receiving NIH Funds
Upcoming Events
Call for Proposals: Brain Tumor Research & Care Symposium
Submit your proposals and save the date for the 3rd annual Brain Tumor Research & Care Symposium.
Human Genetics Research Seminar Series: Hume Stroud, PhD
Part of the Human Genetics Research Seminar Series
Human Genetics Research Seminar Series: Brett A. McCray, MD, PhD
Part of the Human Genetics Research Seminar Series
FEATURED NEWS & STORIES
Minding Memory
Can Your Voice Reveal Early Signs of Alzheimer’s?
In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders.
Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease.
The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
Philanthropy News
A pediatric epilepsy fundraiser that changes lives
Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
Department News
How nature helps the brain recharge
Dr. Hala Darwish explains how nature can help the brain recover from the constant demands of modern life.
Department News
UpNorth Live News / E-bike Report
Helmets are already highly recommended for traditional bikes. But Dr. Steven Broglio, director of the University of Michigan Concussion Center, says for e-bikes, they are a must.
Department News
'We Cannot Distinguish Fake From Real': What We Heard This Week
Brian Callaghan, MD, MS, of the University of Michigan in Ann Arbor, commenting on a study showing gabapentin prescribing surged after Michigan descheduled the drug.
Department News
Gray Areas: Realistic Possibility of Reversing Diabetic Neuropathy
Brian Callaghan, MD, MS, professor of neurology at the University of Michigan, discusses the clinical debate around whether diabetic peripheral neuropathy is reversible if diagnosed and treated early enough.
